510(k) Report

PMA · Approved

Approved

Bayer Immuno 1 Complexed Psa Assay

P990055PMAApproved Sep 8, 2000343-day reviewClass III

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Siemens Healthcare Diagnostics · NAF Antigen (Complexed),Prostate Specific,(Cpsa)

Approved on Sep 8, 2000 through premarket approval, which rests on the device’s own clinical evidence after a 343-day review.

Decided
Sep 8, 2000
Review
343 days
Class
Class III
Product code
NAF
Recalls
None

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

P990055 has 28 supplements since 2001: changes to the approved device, its labelling or its manufacturing, each approved separately.

PMA supplements approved per year

2001: 12002: 42003: 22005: 12006: 12009: 32010: 12012: 12016: 12018: 22019: 12020: 42021: 12022: 12023: 12024: 22025: 1
2001high 4 (2002) · low 0 (2004)2025
View FIG. 1 as a table
YearSupplements approved
20011
20024
20032
20051
20061
20093
20101
20121
20161
20182
20191
20204
20211
20221
20231
20242
20251
FIG. 1 — Supplements to P990055, 2001–2025Source: FDA PMA database

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NAF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All NAF devices

NAF Antigen (Complexed),Prostate Specific,(Cpsa): FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · NAF

1in 2025

2009: 32010: 12012: 12016: 12018: 22019: 12020: 42021: 12023: 12024: 22025: 1
2007high 4 (2020) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NAF

Too few NAF 510(k)s in any year since 2007 to give a median.

Recalls per year · NAF

No recall names NAF since 2007.

Adverse event reports per year · NAF

24in 2019

2007: 22008: 12010: 22011: 32013: 12019: 24
2007high 24 (2019) · low 0 (2009)2025

MAUDE reports naming product code NAF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—02
20080—01
20093—00
20101—02
20110—03
20121—00
20130—01
20140—00
20150—00
20161—00
20170—00
20182—00
20191—024
20204—00
20211—00
20220—00
20231—00
20242—00
20251—00
20260—0—
Cite this page

510(k) Report. “P990055: Bayer Immuno 1 Complexed Psa Assay.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/P990055

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026